A Brazilian pharmaceutical company met with health regulator Anvisa on Monday seeking approval to conduct Phase III clinical trials of Russia's Sputnik V COVID-19 vaccine, which it plans to make in Brazil for national immunization and for export.
[uam ad id= 317182 ]
RIO DE JANEIRO, BRAZIL - The Russian Sputnik V vaccine for Covid-19 is already registered in its country of origin, as well as authorized for emergency use in other countries, including Argentina, Bolivia, Venezuela and Hungary.
União Química chairman Fernando Marques announced on Monday, January 25th that he plans to immediately start phase 3 trials of the Sputnik V vaccine in Brazil after ANVISA (National Health Regulatory Agency) clearance.
The Subscribe to our Premium Membership Plan. Already Subscribed? Login Here